Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INNOVATE Corp. Director's Dealing 2015

Aug 10, 2015

34366_dirs_2015-08-10_8654b6b9-8556-4a09-9769-53ffbfd5db68.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HC2 Holdings, Inc. (HCHC)
CIK: 0001006837
Period of Report: 2015-08-06

Reporting Person: FALCONE PHILIP (Director, CEO, Chairman & President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-08-06 Stock option (Right To Buy) $4.05 D 750000 Disposed 2024-05-21 Common Stock (750000) Direct
2015-08-06 Stock option (Right To Buy) $4.25 A 705882 Acquired 2024-05-21 Common Stock (705882) Direct
2015-08-06 Stock option (Right To Buy) $4.00 D 2667 Disposed 2024-05-21 Common Stock (2667) Direct
2015-08-06 Stock option (Right To Buy) $4.25 A 2510 Acquired 2024-05-21 Common Stock (2510) Direct
2015-08-06 Stock option (Right To Buy) $4.46 D 7527 Disposed 2024-05-21 Common Stock (7527) Direct
2015-08-06 Stock option (Right To Buy) $4.46 A 7084 Acquired 2024-05-21 Common Stock (7084) Direct

Footnotes

F1: Amendment of outstanding options resulting in deemed cancellation of options and grant of replacement options. The options (the "Options") to purchase shares of the common stock of HC2 Holdings, Inc. (the "Company") were issued pursuant anti-dilution provisions of an option agreement, originally dated as of May 21, 2014, and as reformed and clarified on October 26, 2014, between the Company and Philip Falcone (the "Option Agreement"), and were amended to reflect the correct conversion price of the Company's Series A Convertible Participating Preferred Stock (the "Preferred Stock").

F2: The Options vest in three equal annual installments beginning on October 28, 2014, subject to Mr. Falcone's continued employment with the Company on each vesting date, and will become immediately exercisable in the event of a Fundamental Change Transaction (as defined in the Option Agreement). The Options are also contingent on the conversion of the Company's Preferred Stock.